[{"internal_id": 50102061, "Award ID": "U2GGH001658", "Award Amount": 807488.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-08-28", "CFDA Number": "93.326", "Description": "PROTECTING AND IMPROVING HEALTH GLOBALLY: STENGTHENING LIC HEALTH THROUGH SURVEILLANCE, EPIDEMIOLOGIC RESEARCH CAPACITY IN GEORGIA", "Place of Performance Country Code": "GEO", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4ba3ba1b-971b-1672-1e28-680c6ef5dcb4-C", "generated_internal_id": "ASST_NON_U2GGH001658_7523"}, {"internal_id": 151948728, "Award ID": "U01GH002386", "Award Amount": 314000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-08-31", "CFDA Number": "93.326", "Description": "RFA-GH-22-001, MONITORING MORBIDITY, EVALUATION OF NEW DIAGNOSTIC TOOLS; INTERVENTIONS TO REDUCE OR INTERRUPT TRANSMISSION, AND IMPROVING SURVEILLANCE FOR INTESTINAL SCHISTOSOMIASIS.", "Place of Performance Country Code": "KEN", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5465b497-9aa4-f713-ce11-6d5facd5f668-C", "generated_internal_id": "ASST_NON_U01GH002386_7523"}, {"internal_id": 139197812, "Award ID": "U01GH002366", "Award Amount": 5487074.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-08-10", "CFDA Number": "93.326", "Description": "GH21-001, CONDUCTING PUBLIC HEALTH RESEARCH IN THAILAND: TECHNICAL COLLABORATION WITH THE MINISTRY OF PUBLIC HEALTH (MOPH) IN THE KINGDOM OF THAILAND", "Place of Performance Country Code": "THA", "Place of Performance State Code": null, "COVID-19 Obligations": 2664944.0, "Infrastructure Obligations": null, "recipient_id": "67d2d2b4-b93c-e289-1a59-6fc3a2b71ebe-C", "generated_internal_id": "ASST_NON_U01GH002366_7523"}, {"internal_id": 139196582, "Award ID": "U01GH002346", "Award Amount": 14831982.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-08-10", "CFDA Number": "93.326", "Description": "GH21-003, ADVANCING PUBLIC HEALTH RESEARCH IN KENYA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": 5320766.0, "Infrastructure Obligations": null, "recipient_id": "358711ab-dfdd-d789-9d79-6eaf11629381-C", "generated_internal_id": "ASST_NON_U01GH002346_7523"}, {"internal_id": 139742651, "Award ID": "U01GH002338", "Award Amount": 2500001.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-08-19", "CFDA Number": "93.326", "Description": "SICA STUDY: SEROEPIDEMIOLOGICAL INSIGHT INTO COVID-19 TRANSMISSION IN AFRICA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": 2500000.0, "Infrastructure Obligations": null, "recipient_id": "369ac1e4-8d93-3063-b933-3586dffba549-C", "generated_internal_id": "ASST_NON_U01GH002338_7523"}, {"internal_id": 151589719, "Award ID": "U01GH002332", "Award Amount": 649989.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-08-19", "CFDA Number": "93.326", "Description": "EFFECTIVENESS OF COVID-19 VACCINE BOOSTER IN INDONESIA", "Place of Performance Country Code": "GBR", "Place of Performance State Code": null, "COVID-19 Obligations": 649989.0, "Infrastructure Obligations": null, "recipient_id": "c1506e9a-400f-6c30-2f62-de246af26307-C", "generated_internal_id": "ASST_NON_U01GH002332_7523"}, {"internal_id": 110863854, "Award ID": "U01GH002291", "Award Amount": 2580000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2020-09-16", "CFDA Number": "93.326", "Description": "EXCELLENCE IN RESEARCH FOR EMERGING AND REEMERGING DISEASES OF PUBLIC HEALTH INTEREST IN COLOMBIA AT THE NATIONAL INSTITUTE OF HEALTH", "Place of Performance Country Code": "COL", "Place of Performance State Code": null, "COVID-19 Obligations": 1463000.0, "Infrastructure Obligations": null, "recipient_id": "ec1aaf72-4c84-735e-013f-c1f9b691bf56-R", "generated_internal_id": "ASST_NON_U01GH002291_7523"}, {"internal_id": 109190190, "Award ID": "U01GH002290", "Award Amount": 8829061.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2020-08-12", "CFDA Number": "93.326", "Description": "MALARIA OPERATIONS RESEARCH TO IMPROVE MALARIA CONTROL AND REDUCE MORBIDITY AND MORTALITY IN WESTERN KENYA", "Place of Performance Country Code": "KEN", "Place of Performance State Code": null, "COVID-19 Obligations": 4542301.0, "Infrastructure Obligations": null, "recipient_id": "261506ea-41d6-290d-6aec-cdb849a6f3bc-C", "generated_internal_id": "ASST_NON_U01GH002290_7523"}, {"internal_id": 110234649, "Award ID": "U01GH002272", "Award Amount": 1139002.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2020-09-01", "CFDA Number": "93.326", "Description": "CONDUCTING RESEARCH ON DISEASES OF GLOBAL AND LOCAL PUBLIC HEALTH IMPORTANCE TO CREATE SCIENTIFIC BASIS FOR IMPLEMENTATION AND ENHANCEMENT OF PUBLIC HEALTH POLICIES AND PRACTICES IN GEORGIA", "Place of Performance Country Code": "GEO", "Place of Performance State Code": null, "COVID-19 Obligations": 1000000.0, "Infrastructure Obligations": null, "recipient_id": "4ba3ba1b-971b-1672-1e28-680c6ef5dcb4-C", "generated_internal_id": "ASST_NON_U01GH002272_7523"}, {"internal_id": 110233057, "Award ID": "U01GH002270", "Award Amount": 2591400.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2020-09-01", "CFDA Number": "93.326", "Description": "GH20-005, CONDUCTING INTEGRATED INFECTIOUS DISEASE AND PUBLIC HEALTH RESEARCH IN PERU", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": 1750000.0, "Infrastructure Obligations": null, "recipient_id": "d604415e-e1c8-650f-1b30-5e424b71fcf7-C", "generated_internal_id": "ASST_NON_U01GH002270_7523"}, {"internal_id": 139197894, "Award ID": "U01GH002266", "Award Amount": 1460000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-08-02", "CFDA Number": "93.326", "Description": "PROJECT OF FEBRILE ILLNESS SURVEILLANCE IN THE ANDEAN AND AMAZON COUNTRIES (PISAAC)", "Place of Performance Country Code": "PER", "Place of Performance State Code": null, "COVID-19 Obligations": 1460000.0, "Infrastructure Obligations": null, "recipient_id": "619aac2c-81ab-7742-0f8b-e904d0743c37-C", "generated_internal_id": "ASST_NON_U01GH002266_7523"}, {"internal_id": 89522682, "Award ID": "U01GH002262", "Award Amount": 800000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-08-30", "CFDA Number": "93.326", "Description": "ADVANCING INFECTIOUS DISEASE RESEARCH ACROSS NIGERIA (AIDRAN)", "Place of Performance Country Code": "NGA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ddf4caca-a0cc-513a-08f3-09cd734e80f6-R", "generated_internal_id": "ASST_NON_U01GH002262_7523"}, {"internal_id": 89524304, "Award ID": "U01GH002261", "Award Amount": 750000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-07-31", "CFDA Number": "93.326", "Description": "MALARIA OPERATIONS RESEARCH TO IMPROVE MALARIA CONTROL AND REDUCE MORBIDITY AND MORTALITY IN MALAWI", "Place of Performance Country Code": "MWI", "Place of Performance State Code": null, "COVID-19 Obligations": 400000.0, "Infrastructure Obligations": null, "recipient_id": "12ab8a72-8bc6-fad6-f06f-b06f49c2ec8d-R", "generated_internal_id": "ASST_NON_U01GH002261_7523"}, {"internal_id": 89517581, "Award ID": "U01GH002260", "Award Amount": 504298.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-08-19", "CFDA Number": "93.326", "Description": "ADVANCING INFECTIOUS DISEASE DETECTION AND RESPONSE IN VIET NAM", "Place of Performance Country Code": "VNM", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "97320d49-1f3d-8204-d504-8e70c222e20c-C", "generated_internal_id": "ASST_NON_U01GH002260_7523"}, {"internal_id": 89521213, "Award ID": "U01GH002259", "Award Amount": 19387990.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-08-28", "CFDA Number": "93.326", "Description": "ADVANCING PUBLIC HEALTH RESEARCH IN BANGLADESH", "Place of Performance Country Code": "BGD", "Place of Performance State Code": null, "COVID-19 Obligations": 1948511.0, "Infrastructure Obligations": null, "recipient_id": "3e010796-0858-9ad4-ebec-e767f6778f46-C", "generated_internal_id": "ASST_NON_U01GH002259_7523"}, {"internal_id": 89524000, "Award ID": "U01GH002256", "Award Amount": 900000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-08-28", "CFDA Number": "93.326", "Description": "EPIDEMIOLOGY AND IMMUNITY TO EBOLA VIRUS AND OTHER EMERGING VIRAL INFECTIONS IN LIBERIA", "Place of Performance Country Code": "LBR", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7997b0e4-1373-a617-5e8b-0e0e80c459d7-C", "generated_internal_id": "ASST_NON_U01GH002256_7523"}, {"internal_id": 89523163, "Award ID": "U01GH002250", "Award Amount": 400003.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-08-28", "CFDA Number": "93.326", "Description": "ADVANCING INFECTIOUS DISEASES DETECTION AND RESPONSE IN INDONESIA THROUGH IMPROVING PUBLIC HEALTH LABORATORY CAPACITY", "Place of Performance Country Code": "IDN", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a51b594f-6227-b52c-c7b2-43f573a70b7a-C", "generated_internal_id": "ASST_NON_U01GH002250_7523"}, {"internal_id": 89522257, "Award ID": "U01GH002249", "Award Amount": 2083108.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-08-30", "CFDA Number": "93.326", "Description": "ADVANCING INFECTIOUS DISEASE AND RESPONSE IN SENEGAL", "Place of Performance Country Code": "SEN", "Place of Performance State Code": null, "COVID-19 Obligations": 1210000.0, "Infrastructure Obligations": null, "recipient_id": "7dbd30f9-0df5-4ae2-a48d-9d90699aab7c-R", "generated_internal_id": "ASST_NON_U01GH002249_7523"}, {"internal_id": 89524372, "Award ID": "U01GH002248", "Award Amount": 1430003.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-08-28", "CFDA Number": "93.326", "Description": "ACUTE FEBRILE ILLNESS IN UGANDA", "Place of Performance Country Code": "UGA", "Place of Performance State Code": null, "COVID-19 Obligations": 930000.0, "Infrastructure Obligations": null, "recipient_id": "7dc32204-3918-5e76-f43c-aaf4002237f7-C", "generated_internal_id": "ASST_NON_U01GH002248_7523"}, {"internal_id": 68169524, "Award ID": "U01GH002245", "Award Amount": 743000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-08-28", "CFDA Number": "93.326", "Description": "BURDEN AND RISK OF EMERGING INFECTIOUS DISEASES IN GEOGRAPHICAL ZONES OF INDIA (BRIDGE)", "Place of Performance Country Code": "IND", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9c0039f8-a0b6-4c47-e195-64202b6117ed-C", "generated_internal_id": "ASST_NON_U01GH002245_7523"}, {"internal_id": 68171897, "Award ID": "U01GH002243", "Award Amount": 10329075.64, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-08-28", "CFDA Number": "93.326", "Description": "SURVEILLANCE AND RESEARCH FOR THE INNOVATION AND SUSTAINABILITY OF PUBLIC HEALTH ACTIONS", "Place of Performance Country Code": "GTM", "Place of Performance State Code": null, "COVID-19 Obligations": 5575294.0, "Infrastructure Obligations": null, "recipient_id": "e97f1dcb-2063-f705-d544-6c012292955b-C", "generated_internal_id": "ASST_NON_U01GH002243_7523"}, {"internal_id": 68170819, "Award ID": "U01GH002241", "Award Amount": 2669060.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-08-27", "CFDA Number": "93.326", "Description": "AN INTEGRATED SURVEILLANCE PLATFORM FOR INFECTIOUS DISEASES AND THEIR BURDEN ON ANTIBIOTIC RESISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": 744060.0, "Infrastructure Obligations": null, "recipient_id": "358711ab-dfdd-d789-9d79-6eaf11629381-C", "generated_internal_id": "ASST_NON_U01GH002241_7523"}, {"internal_id": 68171372, "Award ID": "U01GH002238", "Award Amount": 4675893.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-08-27", "CFDA Number": "93.326", "Description": "REDUCING THE MORBIDITY AND MORTALITY DUE TO ACUTE FEBRILE ILLNESSES IN CENTRAL AMERICA AND THE DOMINICAN REPUBLIC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": 2449893.0, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_U01GH002238_7523"}, {"internal_id": 68168147, "Award ID": "U01GH002235", "Award Amount": 5415393.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-08-28", "CFDA Number": "93.326", "Description": "AN INTEGRATED ONE HEALTH APPROACH TO DETECT AND RESPOND TO EMERGING DISEASE THREATS IN HIGH-RISK REGIONS OF CENTRAL AMERICA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": 2735393.0, "Infrastructure Obligations": null, "recipient_id": "ddcd398f-5e59-e840-2368-a57b84efdc7d-C", "generated_internal_id": "ASST_NON_U01GH002235_7523"}, {"internal_id": 68170076, "Award ID": "U01GH002231", "Award Amount": 2987500.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-08-24", "CFDA Number": "93.326", "Description": "ENHANCING CAPACITY FOR STRATEGIC AND APPLIED RESEARCH ACTIVITIES IN SUPPORT OF CONTROL AND ELIMINATION OF NEGLECTED TROPICAL DISEASES", "Place of Performance Country Code": "UGA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "549b6dd2-84a3-c9f4-5928-d1a46aeed094-R", "generated_internal_id": "ASST_NON_U01GH002231_7523"}, {"internal_id": 50094274, "Award ID": "U01GH002224", "Award Amount": 1196976.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-20", "CFDA Number": "93.326", "Description": "CONDUCTING PUBLIC HEALTH RESEARCH IN CHINA", "Place of Performance Country Code": "CHN", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f5f9df7d-d2f2-84ad-9694-5ff033f12d2b-C", "generated_internal_id": "ASST_NON_U01GH002224_7523"}, {"internal_id": 50094273, "Award ID": "U01GH002223", "Award Amount": 82612.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-18", "CFDA Number": "93.326", "Description": "GH17-003, S. AFRICA:  SUPPORTING THE NATIONAL HEALTH LABORATORY SERVICES TO EXPAND PUBLIC HEALTH RESEARCH ON FIELD AND LAB INVESTIGATIONS", "Place of Performance Country Code": "ZAF", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2bed8b66-147f-ed1e-d798-428cde4059ce-C", "generated_internal_id": "ASST_NON_U01GH002223_7523"}, {"internal_id": 50094272, "Award ID": "U01GH002190", "Award Amount": 2583768.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-22", "CFDA Number": "93.326", "Description": "OPERATIONAL RESEARCH FOR DISEASE SURVEILLANCE ENHANCEMENT IN UGANDA (ORDISE-U)", "Place of Performance Country Code": "UGA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7dc32204-3918-5e76-f43c-aaf4002237f7-C", "generated_internal_id": "ASST_NON_U01GH002190_7523"}, {"internal_id": 50094269, "Award ID": "U01GH002143", "Award Amount": 28100883.01, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-31", "CFDA Number": "93.067", "Description": "GH16-006: CONDUCTING COMMUNICABLE DISEASE RESEARCH IN KENYA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": 2530000.0, "Infrastructure Obligations": null, "recipient_id": "358711ab-dfdd-d789-9d79-6eaf11629381-C", "generated_internal_id": "ASST_NON_U01GH002143_7523"}, {"internal_id": 50094268, "Award ID": "U01GH002133", "Award Amount": 14921673.9, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-09-01", "CFDA Number": "93.326", "Description": "GH16-006: CONDUCTING PUBLIC HEALTH RESEARCH IN KENYA", "Place of Performance Country Code": "KEN", "Place of Performance State Code": null, "COVID-19 Obligations": 289591.52, "Infrastructure Obligations": null, "recipient_id": "89c66dc5-cbbe-4f3a-8b22-761bf9dcff05-C", "generated_internal_id": "ASST_NON_U01GH002133_7523"}, {"internal_id": 50094262, "Award ID": "U01GH002084", "Award Amount": 19135599.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-26", "CFDA Number": "93.326", "Description": "CONDUCTING PUBLIC HEALTH RESEARCH IN THAILAND: TECHNICAL COLLABORATION WITH THE MINISTRY OF PUBLIC HEALTH", "Place of Performance Country Code": "THA", "Place of Performance State Code": null, "COVID-19 Obligations": 2862119.0, "Infrastructure Obligations": null, "recipient_id": "67d2d2b4-b93c-e289-1a59-6fc3a2b71ebe-C", "generated_internal_id": "ASST_NON_U01GH002084_7523"}, {"internal_id": 50094258, "Award ID": "U01GH001646", "Award Amount": 9608224.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-08-25", "CFDA Number": "93.326", "Description": "INSTITUTIONAL RESEARCH COLLABORATION BETWEEN THE LIVERPOOL SCHOOL OF TROPICAL MEDICINE AND THE CENTERS FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES CE", "Place of Performance Country Code": "UGA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "261506ea-41d6-290d-6aec-cdb849a6f3bc-C", "generated_internal_id": "ASST_NON_U01GH001646_7523"}, {"internal_id": 151144144, "Award ID": "R43GH002390", "Award Amount": 275766.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-08-10", "CFDA Number": "93.326", "Description": "PA21-259, PHS 2021-2 OMNIBUS SOLICITATION OF THE NIH, CDC AND FDA FOR SMALL BUSINESS INNOVATION RESEARCH GRANT APPLICATIONS (PARENT SBIR [R43/R44] CLINICAL", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": 275766.0, "Infrastructure Obligations": null, "recipient_id": "b25cc9f5-285d-dad3-98fa-7c12442b4c68-R", "generated_internal_id": "ASST_NON_R43GH002390_7523"}, {"internal_id": 151145029, "Award ID": "R43GH002389", "Award Amount": 275766.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-08-09", "CFDA Number": "93.326", "Description": "RAPID COVID-19 MUTATION DISCRIMINATION TEST FOR GLOBAL SARS-COV-2 VARIANT SURVEILLANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": 275766.0, "Infrastructure Obligations": null, "recipient_id": "96011922-ab1d-2a32-1f8a-aded2987eec6-C", "generated_internal_id": "ASST_NON_R43GH002389_7523"}, {"internal_id": 151144877, "Award ID": "R43GH002369", "Award Amount": 275766.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-08-09", "CFDA Number": "93.326", "Description": "AUTOMATED LAB IDENTIFICATION AND SORTING (ALIDAS) FOR MOSQUITO SURVEILLANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1c1e473f-4d3b-1026-6507-42ced8cb5e68-C", "generated_internal_id": "ASST_NON_R43GH002369_7523"}, {"internal_id": 140059434, "Award ID": "R43GH002368", "Award Amount": 212083.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-09-07", "CFDA Number": "93.326", "Description": "ELECTROCHEMICAL ASSAY TO MONITOR ANTI-TB ANTIBIOTICS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8750bd3c-8566-e7ef-46bc-f41e3f77ddee-C", "generated_internal_id": "ASST_NON_R43GH002368_7523"}, {"internal_id": 140058372, "Award ID": "R43GH002367", "Award Amount": 230284.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2021-09-07", "CFDA Number": "93.326", "Description": "ULTRASENSITIVE DETECTION OF URINE LAM FOR POINT-OF-CARE DIAGNOSIS OF ALL FORMS OF TUBERCULOSIS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3633b441-f201-90c8-ab16-bc567b1bc9cb-R", "generated_internal_id": "ASST_NON_R43GH002367_7523"}]